Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy

Acta Derm Venereol. 2014 Nov;94(6):721-2. doi: 10.2340/00015555-1852.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Anus Neoplasms / drug therapy*
  • Anus Neoplasms / pathology
  • Buschke-Lowenstein Tumor / drug therapy*
  • Buschke-Lowenstein Tumor / pathology
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / pathology
  • Chemoradiotherapy
  • Genital Neoplasms, Male / drug therapy*
  • Genital Neoplasms, Male / pathology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Isotretinoin / administration & dosage
  • Male
  • Perineum / pathology*
  • Recombinant Proteins / administration & dosage
  • Remission Induction
  • Time Factors
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Isotretinoin